(Q37776518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Mechanism of action and clinical development of platelet thrombin receptor antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

3

Dominick J Angiolillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Masafumi Ueno

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

1 reference

1 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Cardiovascular Therapy

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1191-1200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

Platelet activation and atherothrombosis

8 February 2020

cites work

1 reference

Basic principles of platelet biology and clinical implications

21 January 2018

1 reference

Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial

21 January 2018

1 reference

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

21 January 2018

1 reference

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

21 January 2018

1 reference

Clinical aspects of platelet inhibitors and thrombus formation

21 January 2018

1 reference

How the protease thrombin talks to cells

21 January 2018

1 reference

Protease-activated receptors in hemostasis, thrombosis and vascular biology

21 January 2018

1 reference

Thrombin signalling and protease-activated receptors

21 January 2018

1 reference

Platelet thrombin receptor antagonism and atherothrombosis

21 January 2018

1 reference

Detection of functional receptors for the proteinase-activated-receptor-2-activating polypeptide, SLIGRL-NH2, in rat vascular and gastric smooth muscle

21 January 2018

1 reference

Protease-activated receptor 3 is a second thrombin receptor in humans

21 January 2018

1 reference

Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells

21 January 2018

1 reference

A dual thrombin receptor system for platelet activation

21 January 2018

1 reference

Molecular cloning of a potential proteinase activated receptor

21 January 2018

1 reference

Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects

21 January 2018

1 reference

Protease-activated receptors in cardiovascular health and diseases

21 January 2018

1 reference

Cloning and characterization of human protease-activated receptor 4

21 January 2018

1 reference

Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats.

21 January 2018

1 reference

Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents

21 January 2018

1 reference

Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity

21 January 2018

1 reference

The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale.

21 January 2018

1 reference

Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks

21 January 2018

1 reference

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

21 January 2018

1 reference

Reduced and delayed untwisting of the left ventricle in patients with hypertension and left ventricular hypertrophy: a study using two-dimensional speckle tracking imaging.

21 January 2018

1 reference

Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-

21 January 2018

1 reference

Actions of Thrombin and Other Coagulant and Proteolytic Enzymes on Blood Platelets

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.10.49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20670195%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference